Black Friday iRobot Roomba deals for 2020, including Roomba s9, s9+, i7, 980 & more robovac deals
The government has announced a maximum of 4,000 fans will be allowed in low-risk areas.
Boris Johnson is thrashing out plans with the devolved leaders for families to reunite over Christmas amid hopes that restrictions under the new Covid tier system will be over by Easter. The talks between the Government and the devolved administrations of Scotland, Wales and Northern Ireland are continuing in a bid to find a common approach to household mixing over the festive period. Mr Johnson confirmed on Monday that England will return to a regional tier system from December 2, but was unable to spell out any further details for Christmas.
ANNOUNCEMENT NO. 101 - 24 NOVEMBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451 Attachments No. 101 Managers' transactions Transactions by persons discharging managerial responsibilities and persons
Lionel Messi might be a Manchester man after all.
Donald Trump has accepted that a formal transition can begin for Joe Biden to take office. Mr Biden was declared the “apparent winner” of the US election by a key federal agency, clearing the way for the start of the transition. President Trump, who had refused to concede the election, said he was directing his team to co-operate on the transition but vowed to keep up the fight.
Daniel Dubois and Joe Joyce finally lock horns in an eagerly-anticipated all-London British heavyweight fight this weekend. Only once has Dubois been taken beyond five rounds - in his points win over journeyman Kevin Johnson back in 2018. A decorated amateur who previously claimed Commonwealth and European gold in addition to Olympic silver - at Rio 2016 - and World Championship bronze, Joyce turned professional at the age of 31 and has since racked up 11 wins from as many bouts, with 10 KOs of his own.
Directors had set up rescue refinancing but investors demand better deal
Save on a selection of Dyson cordless vacuum deals at the Black Friday sale, featuring all the latest Cyclone V10 and V11 Animal offers
UK diplomat who saved Chinese woman given traditional bannerChongqing consul-general Stephen Ellison jumped into river to save university student
Travellers arriving in England will be able to end their quarantine period after five days from December 15, if they pay for a coronavirus test that comes back negative. The travel industry welcomed the policy, announced by Transport Secretary Grant Shapps, but described it as "long overdue". Under the new rules, passengers who arrive from a destination not on the Government's travel corridors list will still need to enter self-isolation.
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class; Route of Administration; Application; Distribution Channel, and Geography" report has been added to ResearchAndMarkets.com's offering. The market is expected to reach US$ 71,300.28 million in 2027 from US$ 49,043.38 million in 2019. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Based on drug class, the market is segmented in to acid neutralizers, antidiarrheal and laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others. In 2019, the acid neutralizers segment held the largest share of the market. The biologics segment is expected to grow at the fastest CAGR during the forecast period. The advent of biologics has had a significant impact on the management of inflammatory bowel disease (IBD). Treatment with biologics has led to an improved quality of life for patients living with Crohn's disease and ulcerative colitis, with fewer admissions to the hospital and less side effects from corticosteroids. These are the most recently developed treatments for IBD. Biologic therapies are indicated for people with moderately to severely active disease who have not responded well to conventional therapy. Four of these agents (adalimumab, certolizumab pegol, golimumab and infliximab) target an inflammatory protein called tumor necrosis factor (TNF). Natalizumab and vedolizumab work by blocking certain types of white blood cells from getting into inflamed tissues. Biologics are beneficial for patients with gastrointestinal disorders who are not responding to conventional treatment. For instance, infliximab, which is derived from monoclonal antibodies to tumor necrosis factor is another modifier of the immune system's actions. Infliximab is given as a series of infusions by vein. This drug can be given to treat moderate to severe Crohn's disease that has not responded to other drugs, to treat people with fistulas, and to maintain response when the disease is difficult to control. Vedolizumab and natalizumab are drugs for people who have moderate to severe Crohn's diseasethat have not responded to TNF inhibitors or other immunomodulating drugs. With the increasing number of biologics in pipeline, the segment is expected to grow at a rapid pace during the forecast period. For instance, Takeda Pharmaceutical Company Limited has five candidates in different phases for various GI indications. Sanofi; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; Bausch Health; AstraZeneca; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Bayer AG; Celltrion Healthcare Co. , Ltd; and LEXICON PHARMACEUTICALS, INC. are among the leading companies operating in the gastrointestinal drugs market. Key Topics Covered: 1. Introduction1.1 Scope of the Study1.2 Report Guidance1.3 Market Segmentation2. Gastrointestinal Drugs Market - Key Takeaways3. Research Methodology4. Global Gastrointestinal Drugs- Market Landscape4.1 Overview4.2 PEST Analysis4.3 Expert Opinions5. Gastrointestinal Drugs Market- Key Market Dynamics5.1 Key Market Drivers5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases5.1.2 Increase in Development of Biologics5.2 Market Restraints5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies5.3 Market Opportunities5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates5.4 Future Trends5.4.1 Emergence of Biosimilars5.5 Impact Analysis6. Gastrointestinal Drugs Market - Global Analysis6.1 Global Gastrointestinal Drugs Marker Revenue Forecast And Analysis6.2 Global Gastrointestinal Drugs Market, By Geography - Forecast And Analysis6.3 Market Positioning of Key Players7. Gastrointestinal Drugs Market Analysis - By Drug Class7.1 Overview7.2 Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)7.3 Acid Neutralizers7.3.1 Overview7.3.2 Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)7.4 Antidiarrheal and Laxatives7.5 Anti-Inflammatory Drugs7.6 Antiemetic and Antinauseants7.7 Biologics8. Gastrointestinal Drugs Market Analysis - By Route of Administration8.1 Overview8.2 Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 20278.3 Oral8.3.1 Overview8.3.2 Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)8.4 Parenteral9. Gastrointestinal Drugs Market Analysis - By Application9.1 Overview9.2 Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)9.3 Inflammatory Ulcerative Colitis9.3.1 Overview9.3.2 Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)9.4 Crohn's Disease9.5 Irritable Bowel Syndrome9.6 Gastroenteritis9.7 Celiac Disease10. Gastrointestinal Drugs Market Analysis - By Distribution Channel10.1 Overview10.2 Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 202710.3 Hospital Pharmacies10.3.1 Overview10.3.2 Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)10.4 Retail Pharmacies10.5 Online Pharmacies11. Gastrointestinal Drugs Market Analysis And Forecast To 2027 - Geographical Analysis12. Impact of COVID-19 Pandemic on Global Gastrointestinal Drugs Market13. Gastrointestinal Drugs Market-Industry Landscape13.1 Overview13.2 Growth Strategies Done by the Companies in the Market, (%)13.3 Organic Developments13.4 Inorganic Developments14. Company Profiles14.1 Key Facts14.2 Business Description14.3 Products and Services14.4 Financial Overview14.5 SWOT Analysis14.6 Key Developments SanofiGlaxoSmithKline plcJohnson and Johnson Services, Inc.Bausch HealthAstraZenecaTakeda Pharmaceutical Company LimitedAbbVie Inc.Bayer AGCelltrion Healthcare Co.,LtdLexicon Pharmaceuticals, Inc For more information about this report visit https://www.researchandmarkets.com/r/ru8ywm Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Follow the latest updates
Children in crisis: Councils an ‘invisible crisis’ played out during lockdown as social workers warn surge in domestic violence, alcohol abuse and anxiety has put caseloads at an all-time high
The Chancellor will outline where money will be spent and saved as the UK deals with the economic shock of the pandemic.
Thai police will deploy nearly 6,000 officers on Wednesday for a demonstration at the office that manages the royal fortune by protesters demanding that King Maha Vajiralongkorn give up personal control of the assets. Police said on Tuesday that no protesters would be allowed within 150 metres (450 feet) of the Crown Property Bureau, where royalists have also said they plan to gather in defence of a monarchy that faces its biggest challenge in decades. Piya Tavichai, the deputy head of Bangkok police, said the two groups would be kept apart.
Save on Dyson deals at the Black Friday 2020 sale, including Dyson cooling fans, cordless vacuum cleaners & purifier offers
The Ministry of Health confirmed 18 new COVID-19 cases in Singapore on Tuesday (24 November), taking the country’s total case count to 58,183.
An official from the Saudi Aramco oil company on Tuesday said customers were unaffected by an attack that came from Yemen's Houthi group at a petroleum products distribution plant in the north of Jeddah city. Yemen's Iran-aligned Houthi forces on Monday said they fired a missile at and struck the Jeddah facility. Saudi authorities later confirmed the attack.
AO World revenues have soared by more than 50%, with the online retailer’s boss declaring the first half has been “like no other”. The FTSE 250 company, led by John Roberts, saw high demand for products online in a period that saw swathes of high street retailers have to close for Covid-19 lockdowns.